Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Single Arm, Open Label Study of Artesunate for the Treatment of Human Papilloma Virus Positive High Grade Cervical Intraepithelial Neoplasia (CIN2/3)

NCT07095478 is registered in ClinicalTrials.gov with Metanoic Health Ltd. as lead sponsor.

NCT NCT07095478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07095478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Single Arm, Open Label Study of Artesunate for the Treatment of Human Papilloma Virus Positive High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
Lead sponsor
Metanoic Health Ltd.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
June 30, 2028
Enrollment
28 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cin 2/3